Showing 21-23 of 23 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Newly identified novel autoantibodies specific to β-cell surface ZnT8 antigen as an early biomarker in type 1 diabetes | Regents of the University of Colorado | Xiaofan Jia | Cures | 01-September-2023 to 28-February-2026 | $499,998.96 |
| Anti-Serpin B13 Hu-mAb Lead Candidate Developability Assessment | Mosaic Biosciences, Inc. | Malavi Madireddi | Cures | 01-June-2025 to 01-April-2026 | $293,674.00 |
| Engineered Nanocapsules for Targeted Drug Delivery to the β-Cell | Colorado School of Mines | Nikki Farnsworth | Cures | 01-April-2023 to 31-March-2026 | $900,000.00 |